FindTrial
Sign In

Comparative study of the efficacy of adriamycin and liposome doxorubicin in the treatment of osteosarcoma

Comparative study of the efficacy of adriamycin and liposome doxorubicin in the treatment of osteosarcoma

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016574
Enrollment
Unknown
Registered
2018-06-10
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Interventions

Case series:Chemotherapy

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The pathology diagnosis should be osteosaroma; 2. The patients should receive pre-operative chemotherapy; 3. The tumor could be used to have the necrosis evaluation.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
Necrosis rate;—

Countries

China

Contacts

Public ContactLi Yuan

Beijing Jishuitan Hospital

liyuanmails@126.com+86 13701200785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026